Education
About Us
Working with TipRanks
Follow Us
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
KZIA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.76 - $15.80
Previous CloseN/A
Volume31.49K
Average Volume (3M)270.04K
Market Cap
$4.92M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$3.56M
Total Debt (Recent Filing)AU$359.30K
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Aug 28, 2025EPS Estimate
-1.39Last Dividend Ex-Date
Jan 28, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)-6.66
Shares Outstanding5,589,294
10 Day Avg. Volume52,700
30 Day Avg. Volume270,038
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.94
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$3.00Price Target Upside240.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Kazia Therapeutics News
---
Bulls Say, Bears Say
Bulls Say
Market OpportunityPaxalisib has shown numerical overall survival benefits in studies involving glioblastoma patients, presenting an attractive opportunity due to the lack of progress in treatment options.
Research GrantA research grant was awarded to Kazia to evaluate paxalisib as a treatment for Parkinson's disease, highlighting a novel opportunity for the company.
Bears Say
Financial NeedsAdditional capital will likely be required to continue clinical operations, which can occur in various forms.
---
Ownership Overview
―
Insiders
0.03% Mutual Funds
― Other Institutional Investors
99.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
KZIA FAQ
What was Kazia Therapeutics Limited’s price range in the past 12 months?
Kazia Therapeutics Limited lowest stock price was $0.76 and its highest was $15.80 in the past 12 months.
What is Kazia Therapeutics Limited’s market cap?
Kazia Therapeutics Limited’s market cap is $4.92M.
When is Kazia Therapeutics Limited’s upcoming earnings report date?
Kazia Therapeutics Limited’s upcoming earnings report date is Aug 28, 2025 which is in 150 days.
How were Kazia Therapeutics Limited’s earnings last quarter?
Currently, no data Available
Is Kazia Therapeutics Limited overvalued?
According to Wall Street analysts Kazia Therapeutics Limited’s price is currently Undervalued.
Does Kazia Therapeutics Limited pay dividends?
Kazia Therapeutics Limited pays a Notavailable dividend of $156.513 which represents an annual dividend yield of N/A. See more information on Kazia Therapeutics Limited dividends here
What is Kazia Therapeutics Limited’s EPS estimate?
Kazia Therapeutics Limited’s EPS estimate is -1.39.
How many shares outstanding does Kazia Therapeutics Limited have?
Kazia Therapeutics Limited has 5,589,294 shares outstanding.
What happened to Kazia Therapeutics Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kazia Therapeutics Limited?
Currently, no hedge funds are holding shares in KZIA
---
Company Description
Kazia Therapeutics Limited
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
---
KZIA Stock 12 Month Forecast
Average Price Target
$3.00
▲(240.91% Upside)
Technical Analysis
Best Analysts Covering KZIA
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-52.43%
reiterated a buy rating 9 months ago
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -52.43% per trade.
---